| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | CA2236896C 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006050359A3 Pyridazine compounds and methods |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087602 Cinnoline derivatives and use as medicine |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/03/2006 | WO2006080323A1 Six-membered heterocyclic compound and the use thereof |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173012 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy |
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/01/2006 | US7084163 Applying to plants |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006036981A3 Small molecule modulators of cytokine activity |
| 07/27/2006 | WO2006009937A3 Novel esters as useful broad spectrum herbicidal compounds |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060166996 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682508A1 Phenyl derivatives as ppar agonists |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | US20060160812 1-Substituted-3,5-distyrylpyrazoles; protect neurons and promote neuroregeneration and memory formation; treatments for acute neural injuries (such as stroke and spinal cord injury) and chronic neurodegenerative diseases |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/13/2006 | WO2005112945A3 Synthesis of tetracyclines and analogues thereof |
| 07/13/2006 | US20060155127 sulfonating aromatic polyether containing phthlazine ring with a mixture of concentrated and fuming sulfuric acid in preferred ratio to form sulfonated polyphthalazione ethers; casting to form proton exchange membrane; electrolyte fuel cells |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | CA2593005A1 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 07/12/2006 | CN1263746C Pyridazinone derivatives |
| 07/11/2006 | US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity. |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/11/2006 | CA2123731C Process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds and their use |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/06/2006 | WO2006050389A3 Pyridazine compounds, compositions and methods |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/05/2006 | EP1676842A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
| 06/29/2006 | US20060142553 Novel azo dye compound |
| 06/29/2006 | US20060142293 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/22/2006 | US20060135517 Imidazolopyridines and methods of making and using the same |
| 06/22/2006 | US20060135367 2,5 -Difluoro-N-isobutyl-N-(8-propyl-[1,2,4]triazolo,[1,5-c]pyrimidin-7-ylmethyl)-benzamide; gamma aminobutyric acid receptor (GABAR) agonist/antagonist; anxiolitic, antidepressant; sleep disorder, attention deficit disorder, schizophrenia or Alzheimer's dementia |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1670794A2 Vanilloid receptor ligands and their use in treatments |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670763A1 Cyclopentene compounds |
| 06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1259321C Substituted benzene fused heterocycle herbicides |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/08/2006 | WO2006060127A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/08/2006 | WO2006060122A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | CA2588949A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 06/08/2006 | CA2588947A1 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/01/2006 | WO2006028957A8 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |